US Gastroenterologists Report VARSITY Trial Data and JAK Inhibitor Safety Concerns Will Impact Their Prescribing Behavior in Ulcerative Colitis, with Potential Implications for Crohn's Treatment

[In The News]

EXTON, Pa., June 5, 2019 /PRNewswire/ -- While both the ulcerative colitis (UC) and Crohn's disease markets have remained relatively stable since the prior quarter in terms of brand share and user base, Spherix captured reactions to recent key market events that could begin to ripple...

View the full article